MUC1 and adrenal cortex carcinoma: Excitingly, several more ACC lines have been reported in the last few years, including MUC-1 cell lines in 2016, and CU-ACC1 and CU-ACC2 in 2018 (all three with companion PDX lines for comparison) [55,56].